Gray font color on white background Black font color on white background White font color on black background White font color on dark blue background
Font Size

Clinical Trials » Stargardt Disease
PDF Print E-mail Bookmark Share This Page

Subretinal Implant: Retina AG


Retina AG, a German developer of subretinal implants, is conducting international clinical evaluations of its subretinal implant for providing limited vision to people with advanced retinal degenerative diseases such as retinitis pigmentosa. The company reported that a majority of 11 subjects in the study were able to “pick out” bright objects. The chip, placed behind the macula, works by converting light entering the eye into electrical impulses which are then sent to the optic nerve. The device has been in human evaluations since 2005. Current clinical evaluation sites are located in: Germany, United Kingdom, Hungary, Italy, and the United States (Wills Eye Institute, Philadelphia).

Trial Status:
Ongoing; recruiting participants.

Additional Information:

Retina AG’s clinical trial listing on

Back to top

US Images


Select a state from the dropdown below to view local chapters.

Free Information

Register here to receive free information about your eye condition and research efforts to find treatments and cures.

2013 Annual Report banner
VisionWalk banner
Events Calendar